Navigation Links
Medco Announces Organizational Changes
Date:9/25/2008

FRANKLIN LAKES, N.J., Sept. 25 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) today announced the following organizational changes to further enhance its products and services for clients and members:

Timothy Wentworth has been named Group President, Employer Accounts, effective immediately. Formerly president and CEO of Accredo Health Group, Inc., Tim will now lead Medco's Employer Accounts Customer Group, responsible for Medco's self-insured clients, large and small; and

Steven Fitzpatrick, formerly chief operating officer of Accredo, will assume the role of President of Accredo, responsible for continuing the momentum of specialty pharmacy as one of the fastest growing segments in health care and advancing the company's high marketplace performance and clinical excellence.

"With its new scale, the timing is right to optimize and leverage Medco's operational capabilities, while at the same time honoring Accredo's unique attributes -- including deep relationships with patients, physicians, payors and pharmaceutical manufacturers," said Kenny Klepper, Medco president and chief operating officer. "These changes underscore the synergies possible across all our business organizations, and I am confident that Tim and Steve will continue to take these positions to new heights.

"During his tenure in Memphis, Tim led the rapid and successful integration of Accredo into the mainstream of Medco. At the time of the acquisition, Accredo contributed about $3 billion in revenue; today it's on track to exceed $7 billion.

"Steve has distinguished himself as a dynamic business executive with a deep understanding of Accredo's business. Along with his Memphis-based leadership team, Steve will continue Tim's good work and will take the next steps in sharing Accredo's best practices across Medco, while at the same time tapping Medco's resources to the benefit of Accredo."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is the nation's leading pharmacy benefit manager based on its 2007 total net revenues of more than $44 billion. Medco's prescription drug benefit programs, covering approximately one-in-five Americans, are designed to drive down the cost of pharmacy health care for private and public employers, health plans, labor unions and government agencies of all sizes, for individuals served by the Medicare Part D Prescription Drug Program, and those served by Medco's specialty pharmacy segment, Accredo Health Group. Medco, the world's most advanced pharmacy(R), is positioned to serve the unique needs of patients with chronic and complex conditions through its Medco Therapeutic Resource Centers(R), including its enhanced diabetes pharmacy care practice through the Liberty acquisition. Medco is the highest-ranked independent pharmacy benefit manager on the 2008 Fortune 100 list. On the Net: http://www.medco.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion
2. Medco Announces Research Collaboration with FDA Focused on Personalized Medicine
3. Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference
4. Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance
5. Coventry Health Care Awards Medicare Pharmacy Services Contract to Medco
6. Medco to Present at the William Blair & Company, L.L.C. 28th Annual Growth Conference
7. Medco CEO to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
8. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
9. Medco to Present at the Bank of America 2008 Health Care Conference
10. Medco Joins Cincinnatis Cover the Uninsured Week Effort To Deliver Lower Cost Health Care
11. Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... supply chain solutions, today announced the organization has earned its ISO 13485 certification, ... and is compliant with all rules and policies associated with ISO quality standard ...
(Date:5/26/2016)... New York, NY (PRWEB) , ... May 26, ... ... cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon ... Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & ... over 20 years of experience in leading technology and human resources operations for ... university teaching, Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
Breaking Medicine Technology: